Exchange: NASDAQ·Updated 07:34 PM EDT
ABUS logo

ABUSArbutus Biopharma Corp

$4.38
$0.09
(2.01%)
Today
Closed $4.38
$0.009
(0.20%)
After Hours
EarningsAug 5
Mkt Cap$865.22M
Vol876,895.00
News
all
press releases
ABUS Stock On Track For Best Day In About Two Months — What’s The Moderna Connection?
On July 8, Arbutus received around $178 million from Moderna as part of a patent litigation settlement, the company said.
Stocktwits
More News
ABUS Stock Rallies Ahead Of Big Payout From Moderna Settlement This Week
Arbutus expects to receive around $179 million from Moderna.
Stocktwits
Moderna's Revenues See Strong International Momentum in Q1 Earnings
MRNA's Q1 revenues soar 260% on strong international vaccine sales, while cost cuts and new EU approvals support its broader growth strategy.
Zacks
QuidelOrtho, MIND Technology, Southern First Bancshares And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
U.S. stock futures up, QuidelOrtho shares down in pre-market trading. Allbirds, MIND, Arbutus Biopharma among other stocks also falling.read more...
Benzinga
Arbutus Biopharma (NASDAQ:ABUS) Sees Large Volume Increase - Here's Why
Arbutus Biopharma (NASDAQ:ABUS) Sees Large Volume Increase - What's Next...
MarketBeat
Arbutus Biopharma (NASDAQ:ABUS) Stock Price Crosses Above 200-Day Moving Average - What's Next?
Arbutus Biopharma (NASDAQ:ABUS) Share Price Passes Above 200 Day Moving Average - Time to Sell...
MarketBeat
Arbutus Biopharma (NASDAQ:ABUS) Posts Earnings Results
Arbutus Biopharma (NASDAQ:ABUS - Get Free Report) posted its quarterly earnings data on Monday. The biopharmaceutical company reported ($0.01) EPS for the quarter, beating analysts' consensus estimates of ($0.06) by $0.05. The business had revenue of $1.05 million for the quarter, compared to...
MarketBeat
Arbutus Biopharma (ABUS) Projected to Post Quarterly Earnings on Thursday
Arbutus Biopharma (NASDAQ:ABUS) will be releasing its Q4 2025 earnings before the market opens on Thursday, March 26. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-3-26-arbutus-biopharma-co-stock...
MarketBeat
Foursixthree Capital LP Has $8.99 Million Stake in Arbutus Biopharma Corporation $ABUS
Foursixthree Capital LP decreased its holdings in shares of Arbutus Biopharma Corporation (NASDAQ:ABUS - Free Report) by 22.6% during the 3rd quarter, according to the company in its most recent Form...
MarketBeat
Arbutus Biopharma (NASDAQ:ABUS) Shares Down 8.4% - Time to Sell?
Arbutus Biopharma (NASDAQ:ABUS) Trading Down 8.4% - What's Next...
MarketBeat
<
1
2
...
>

Advertisement|Remove ads.